
### [MONDO:0018541](http://purl.obolibrary.org/obo/MONDO_0018541)
**Label:** familial hypoaldosteronism

**Subclasses:** [MONDO:0020489](http://purl.obolibrary.org/obo/MONDO_0020489) (familial hyperreninemic hypoaldosteronism type 1), 

**Corr. equiv. classes:** [OMIM:203400](http://purl.obolibrary.org/obo/OMIM_203400), [OMIM:610600](http://purl.obolibrary.org/obo/OMIM_610600), [Orphanet:99763](http://www.orpha.net/ORDO/Orphanet_99763), 

**Class expressions from DL-Learner:**

- [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0012591](http://purl.obolibrary.org/obo/HP_0012591) (Abnormal urinary electrolyte concentration) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 83.33%
- [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0011277](http://purl.obolibrary.org/obo/HP_0011277) (Abnormality of the urinary system physiology) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 83.33%
- [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 83.33%
- [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0010931](http://purl.obolibrary.org/obo/HP_0010931) (Abnormality of sodium homeostasis) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 83.33%
- [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 83.33%
- [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0004323](http://purl.obolibrary.org/obo/HP_0004323) (Abnormality of body weight) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 83.33%
- [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0012591](http://purl.obolibrary.org/obo/HP_0012591) (Abnormal urinary electrolyte concentration) 83.33%
- [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0011277](http://purl.obolibrary.org/obo/HP_0011277) (Abnormality of the urinary system physiology) 83.33%
- [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 83.33%
- [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0010931](http://purl.obolibrary.org/obo/HP_0010931) (Abnormality of sodium homeostasis) 83.33%
- [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) 83.33%
- [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0004323](http://purl.obolibrary.org/obo/HP_0004323) (Abnormality of body weight) 83.33%
- [HP:0003623](http://purl.obolibrary.org/obo/HP_0003623) (Neonatal onset) and [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0012591](http://purl.obolibrary.org/obo/HP_0012591) (Abnormal urinary electrolyte concentration) 83.33%
- [HP:0003623](http://purl.obolibrary.org/obo/HP_0003623) (Neonatal onset) and [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0011277](http://purl.obolibrary.org/obo/HP_0011277) (Abnormality of the urinary system physiology) 83.33%
- [HP:0003623](http://purl.obolibrary.org/obo/HP_0003623) (Neonatal onset) and [HP:0004319](http://purl.obolibrary.org/obo/HP_0004319) (Decreased circulating aldosterone level) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 83.33%


